[A case with liver resection of metastasis from rectal cancer after bevacizumab treatment].

Abstract

The advancement of systemic chemotherapy for colorectal carcinoma has improved a clinical response rate and expanded a possibility of resection, which we thought we could not have been operable at the initial visit. It also improved a prognosis of patients. We report here a case with liver resection of metastasis from rectal cancer followed by bevacizumab treatment.

• Authors: Kiyotaka Nishida, Takatoshi Matsuyama, Daiki Masuda, Takashi Hosokawa, Hiromi Tokita, Masaki Kakimoto, Hiroshi Goto, Tetsunori Yoshimura, Haruya Koshiishi, Takashi Okamura
• Journal: Gan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 37 Issue 12 Pg. 2517-9 (Nov 2010) ISSN: 0385-0684 [Print] Japan
• PMID: 21224625 (Publication Type: Case Reports, English Abstract, Journal Article)

Chemical References

• Angiogenesis Inhibitors
• Antibodies, Monoclonal
• Antibodies, Monoclonal, Humanized
• Organoplatinum Compounds
• Bevacizumab
• Leucovorin
• Fluorouracil
• Camptothecin

Topics

• Angiogenesis Inhibitors (administration & dosage)
• Antibodies, Monoclonal (administration & dosage)
• Antibodies, Monoclonal, Humanized
• Antineoplastic Combined Chemotherapy Protocols (administration & dosage, therapeutic use)
• Bevacizumab
• Camptothecin (administration & dosage, analogs & derivatives)
• Fluorouracil (administration & dosage)
• Hepatectomy
• Humans
• Leucovorin (administration & dosage)
• Liver Neoplasms (secondary, therapy)
• Male
• Middle Aged
• Organoplatinum Compounds (administration & dosage)
• Rectal Neoplasms (pathology, surgery)
• Reoperation